Molecular Biomedicine is a peer-reviewed english-language open-access journal published by Springer in Switzerland, operating under an open-access model since 2020. The journal covers Medicine.
Authors are required to pay an article processing charge to publish in Molecular Biomedicine; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY, Publisher's own license license (see other journals using this license).
To date, Molecular Biomedicine has published 445 articles. Articles are minted with DOIs through the prefix 10.1186. All submissions undergo plagiarism screening before peer review.
Keywords
biomedicine, genetics, bioinformatics, molecular biology, gene editing
At a glance
- Publisher
- Springer
- Country
- Switzerland
- Primary language
- English
- License
- CC BY, Publisher's own license
- Peer review
- Anonymous peer review
- OA since
- 2020
- Review time
- 10 weeks
- DOI prefix
10.1186- Plagiarism check
- Yes
ISSN
- electronic
- 2662-8651
Frequently asked questions
Is Molecular Biomedicine peer-reviewed?
Does Molecular Biomedicine charge an article processing charge (APC)?
What subjects does Molecular Biomedicine publish?
What languages does Molecular Biomedicine accept?
What is the ISSN of Molecular Biomedicine?
2662-8651 (electronic).